Daniel Craig Wiener, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Esophageal Fistula | 1 | 2021 | 59 | 0.740 |
Why?
|
| Bronchial Fistula | 1 | 2021 | 83 | 0.730 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2021 | 156 | 0.650 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2015 | 296 | 0.600 |
Why?
|
| Hernia, Hiatal | 1 | 2019 | 90 | 0.590 |
Why?
|
| Cardiac Tamponade | 1 | 2019 | 175 | 0.580 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2018 | 154 | 0.530 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2020 | 281 | 0.520 |
Why?
|
| Endoscopy, Digestive System | 1 | 2019 | 358 | 0.520 |
Why?
|
| Fundoplication | 1 | 2016 | 146 | 0.490 |
Why?
|
| Esophageal pH Monitoring | 1 | 2016 | 203 | 0.480 |
Why?
|
| Esophageal Neoplasms | 3 | 2021 | 1660 | 0.470 |
Why?
|
| Pneumonectomy | 2 | 2015 | 1147 | 0.450 |
Why?
|
| Neuromyelitis Optica | 1 | 2018 | 266 | 0.450 |
Why?
|
| Adenocarcinoma | 4 | 2021 | 6359 | 0.430 |
Why?
|
| Electric Impedance | 1 | 2016 | 791 | 0.380 |
Why?
|
| Lung Neoplasms | 6 | 2021 | 13485 | 0.340 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 1445 | 0.330 |
Why?
|
| Patient Selection | 1 | 2016 | 4252 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3636 | 0.200 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3236 | 0.180 |
Why?
|
| Carcinoma, Large Cell | 1 | 2021 | 114 | 0.180 |
Why?
|
| Truth Disclosure | 1 | 2004 | 433 | 0.180 |
Why?
|
| Esophagectomy | 2 | 2021 | 478 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5753 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5387 | 0.150 |
Why?
|
| Laparoscopy | 3 | 2019 | 2039 | 0.130 |
Why?
|
| Syncope | 1 | 2019 | 431 | 0.130 |
Why?
|
| Elastin | 1 | 2017 | 299 | 0.130 |
Why?
|
| Bronchoscopy | 1 | 2021 | 913 | 0.120 |
Why?
|
| Williams Syndrome | 1 | 2017 | 195 | 0.120 |
Why?
|
| Cough | 1 | 2019 | 599 | 0.120 |
Why?
|
| Lymphoma | 1 | 2021 | 1900 | 0.100 |
Why?
|
| Remission Induction | 1 | 2018 | 2413 | 0.100 |
Why?
|
| Pulmonary Emphysema | 1 | 2017 | 683 | 0.100 |
Why?
|
| Immunotherapy, Active | 1 | 2010 | 58 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2234 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2010 | 282 | 0.080 |
Why?
|
| Natural Language Processing | 1 | 2018 | 1203 | 0.080 |
Why?
|
| Retrospective Studies | 10 | 2021 | 81635 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2019 | 2976 | 0.080 |
Why?
|
| Aged | 8 | 2021 | 171343 | 0.080 |
Why?
|
| Male | 12 | 2021 | 364142 | 0.080 |
Why?
|
| Esophagoscopy | 1 | 2009 | 398 | 0.070 |
Why?
|
| Humans | 22 | 2021 | 766766 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9404 | 0.070 |
Why?
|
| Survival Rate | 3 | 2021 | 12825 | 0.070 |
Why?
|
| Head | 1 | 2012 | 926 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 3266 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 1931 | 0.070 |
Why?
|
| Terminal Care | 1 | 2018 | 1769 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65273 | 0.060 |
Why?
|
| Communication | 1 | 2020 | 3905 | 0.060 |
Why?
|
| Lymph Nodes | 3 | 2021 | 3468 | 0.060 |
Why?
|
| Barrett Esophagus | 1 | 2009 | 494 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2015 | 4188 | 0.060 |
Why?
|
| Radiotherapy, Conformal | 1 | 2007 | 545 | 0.060 |
Why?
|
| Medical Audit | 1 | 2006 | 454 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 1287 | 0.060 |
Why?
|
| Catheterization | 1 | 2009 | 1429 | 0.060 |
Why?
|
| Catheter Ablation | 2 | 2009 | 2786 | 0.060 |
Why?
|
| Prognosis | 4 | 2021 | 29948 | 0.050 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 11218 | 0.050 |
Why?
|
| Middle Aged | 9 | 2021 | 223257 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2021 | 2901 | 0.050 |
Why?
|
| Pancreatectomy | 1 | 2007 | 825 | 0.050 |
Why?
|
| Cancer Vaccines | 1 | 2010 | 1042 | 0.050 |
Why?
|
| Palliative Care | 1 | 2018 | 3640 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3832 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2016 | 8728 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 3935 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2012 | 2654 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20708 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2006 | 863 | 0.040 |
Why?
|
| Pleural Neoplasms | 1 | 2004 | 584 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 24295 | 0.040 |
Why?
|
| Mesothelioma | 1 | 2004 | 774 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2004 | 1497 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 59550 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39309 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2017 | 310 | 0.030 |
Why?
|
| Quality of Life | 1 | 2018 | 13476 | 0.030 |
Why?
|
| SEER Program | 1 | 2021 | 1443 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2021 | 1012 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 3108 | 0.030 |
Why?
|
| Critical Care | 1 | 2008 | 2714 | 0.030 |
Why?
|
| Critical Illness | 1 | 2008 | 2750 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 334 | 0.030 |
Why?
|
| Female | 8 | 2021 | 396520 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2020 | 1267 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 2 | 2021 | 2902 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 11513 | 0.030 |
Why?
|
| Insulin | 1 | 2008 | 6608 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2008 | 6422 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 40149 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 7871 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 74881 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 1384 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2021 | 15831 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 2510 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2010 | 132 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6512 | 0.020 |
Why?
|
| Receptor, TIE-2 | 1 | 2010 | 183 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 5444 | 0.020 |
Why?
|
| Angiopoietin-2 | 1 | 2010 | 186 | 0.020 |
Why?
|
| Cattle | 1 | 2015 | 3815 | 0.020 |
Why?
|
| Gene Library | 1 | 2010 | 1065 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2010 | 557 | 0.020 |
Why?
|
| United States | 1 | 2015 | 72951 | 0.020 |
Why?
|
| Adult | 4 | 2016 | 223307 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2010 | 608 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12534 | 0.020 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2006 | 28 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2010 | 1392 | 0.020 |
Why?
|
| Glycemic Index | 1 | 2008 | 400 | 0.020 |
Why?
|
| Quebec | 1 | 2006 | 140 | 0.020 |
Why?
|
| Urinary Retention | 1 | 2006 | 100 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13643 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2007 | 1787 | 0.010 |
Why?
|
| Urinary Tract | 1 | 2006 | 305 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 2006 | 418 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2017 | 6612 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 642 | 0.010 |
Why?
|
| Neoplasms | 1 | 2010 | 22350 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8735 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2008 | 896 | 0.010 |
Why?
|
| North America | 1 | 2004 | 1287 | 0.010 |
Why?
|
| Hematoma | 1 | 2006 | 766 | 0.010 |
Why?
|
| Leiomyoma | 1 | 2006 | 644 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 2631 | 0.010 |
Why?
|
| Morbidity | 1 | 2006 | 1754 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2010 | 4032 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3511 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16724 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2008 | 1790 | 0.010 |
Why?
|
| Europe | 1 | 2004 | 3430 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 6779 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 6850 | 0.010 |
Why?
|
| Intestines | 1 | 2006 | 1904 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18330 | 0.010 |
Why?
|
| Reoperation | 1 | 2006 | 4325 | 0.010 |
Why?
|
| Sepsis | 1 | 2008 | 2604 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2008 | 5343 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8540 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2006 | 3799 | 0.010 |
Why?
|
| Melanoma | 1 | 2010 | 5700 | 0.010 |
Why?
|
| Length of Stay | 1 | 2006 | 6490 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2006 | 3283 | 0.010 |
Why?
|
| Animals | 2 | 2015 | 168930 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2006 | 4904 | 0.000 |
Why?
|
| Incidence | 1 | 2004 | 21525 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2007 | 41710 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 81889 | 0.000 |
Why?
|